Inventor · disambiguated record
Michael A. Fischbach
Also filed as: FISCHBACH MICHAEL · FISCHBACH MICHAEL A
9 granted patents·8 pending applications·10 citations·filing 2005–2023
81Inventor score
Files withCHAN ZUCKERBERG BIOHUB INC4MAYO FOUND MEDICAL EDUCATION & RES4CALIFORNIA INST OF TECHN2HARVARD COLLEGE2UNIV CALIFORNIA2
Top patents by PatentIndex Score
17 records- 0187US10300043B2Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereofMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted May 28, 2019·4 cites·15 claims
- 0286US11878002B2Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disordersMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Granted Jan 23, 2024·2 cites·8 claims
- 0380US10993930B2Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disordersMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted May 4, 2021·2 cites·15 claims
- 0478US11224624B2Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and diseaseCALIFORNIA INST OF TECHN·Filed 2018·Granted Jan 18, 2022·1 cites·20 claims
- 0577US12257235B2Methods and materials for using ruminococcus gnavus or clostridium sporogenes to treat gastrointestinal disordersMAYO FOUND MEDICAL EDUCATION & RES·Filed 2023·Granted Mar 25, 2025·0 cites·11 claims
- 0667US11744867B2Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and diseaseCALIFORNIA INST OF TECHN·Filed 2021·Granted Sep 5, 2023·0 cites·17 claims
- 0765US2025290093A1High capacity lentiviral vectorsCZ BIOHUB SAN FRANCISCO LLC·Filed 2023·Application pending·0 cites
- 0862US10227290B2Glycosphingolipids for use in modulating immune responsesUNIV CALIFORNIA·Filed 2013·Granted Mar 12, 2019·1 cites·12 claims
- 0954US12103946B2Steroid compounds as Treg modulators and uses thereofUNIV NEW YORK·Filed 2019·Granted Oct 1, 2024·0 cites·5 claims
- 1052US2024024380A1Bacteria-engineered to elicit antigen-specific t cellsCHAN ZUCKERBERG BIOHUB INC·Filed 2021·Application pending·0 cites
- 1147US2023233620A1High-complexity synthetic gut bacterial communitiesCHAN ZUCKERBERG BIOHUB INC·Filed 2021·Application pending·0 cites
- 1246US2022023354A1High complexity synthetic gut bacterial communitiesCHAN ZUCKERBERG BIOHUB INC·Filed 2019·Application pending·0 cites
- 1345US11124498B2Compositions and methods for modulating protease activityUNIV CALIFORNIA·Filed 2017·Granted Sep 21, 2021·0 cites·20 claims
- 1445US2022362358A1Bacteria-engineered to elicit antigen-specific t-cellsCHAN ZUCKERBERG BIOHUB INC·Filed 2020·Application pending·0 cites
- 1544US2006280029A1Microfluidic mixerHARVARD COLLEGE·Filed 2005·Application pending·0 cites
- 1643US2010048422A1Methods of Producing Modified Assembly Lines and Related CompositionsWALSH CHRISTOPHER T·Filed 2006·Application pending·0 cites
- 1735US2009097808A1Fluid waveguide and uses thereofHARVARD COLLEGE·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →